Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system

Inclusion Criteria: * Age of 18 to 95 years * Male or non-pregnant female * De novo lesions\>70% or occlusions in the SFA (Superficial Femoral Artery) arteries suitable for stent angioplasty * Max. 1 lesion within each leg should be treated as study lesions * Lesions length range from ≥3 cm to ≤18 cm * A patent inflow artery free from significant lesions (\>50 % stenosis) as confirmed by angiography. Treatment of target lesion acceptable after successful treatment of inflow artery lesions. * Reference vessel diameter ≥3 mm and ≤ 7 mm * Successful guide wire passage of the lesion * Symptomatic peripheral artery disease (Rutherford stage 2 to 5) * Patient is willing to provide informed consent and comply with the required follow-up visits, testing schedule, and medication regimen Exclusion Criteria: * Patients for whom an anti-platelet therapy, anticoagulants or thrombolytics are contraindicated * Patients presenting a lasting intraluminal thrombosis at the lesion after a thrombolytic therapy * Perforation at the location of the angioplasty characterized by secretion of the contrast medium * Aneurysm of the artery to be treated * All common contraindications for a PTA (Percutaneous Transluminal Angioplasty) * Contraindications for stent angioplasty * Hypersensitivity/allergy to nickel-titanium * Hypersensitivity/allergy to any of the components of the delivery \& dilation system * Severe renal insufficiency (creatinine\>2.0 mg/dL or glomerular filtration rate \< 60 ml/min/1.73) * Uncorrected bleeding disorder * Major gastrointestinal bleeding within the last 6 months. * Ipsilateral intervention other than target vessel * Untreated ipsilateral iliac artery stenosis \>70 % * Previous stenting or prior surgery of the SFA * In-stent restenosis * Acute myocardial infarct within 72 h * Less than one patent crural artery * Popliteal stenosis \> 70 % * Manifest hyperthyroidism * Acute onset of symptoms * Leg-threatening ischemia * Multimorbid patient with poor general condition * Pregnant woman or becoming pregnant in \< 2 yrs * Living more than 100 km apart from the study center * Patient actively participating in another investigational device or drug study * History of hemorrhagic stroke within 3 months * Previous or planned surgical or interventional procedure within 30 days of the procedure * Acute or sub-acute thrombus in target vessel * Acute vessel occlusion or sudden symptom onset * Lesions in target area requiring atherectomy (or ablative devices), cutting balloons, cryoplasty balloons, or any other advanced device to facilitate angioplasty balloon or stent delivery * Use of adjunctive therapies (i.e. laser, atherectomy, cryoplasty, scoring/cutting balloon, etc.)